VistaGen Therapeutics
VTGN
VTGN
49 hedge funds and large institutions have $39M invested in VistaGen Therapeutics in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 20 reducing their positions, and 9 closing their positions.
Holders
49
Holders Change
-5
Holders Change %
-9.26%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
12
Reduced
20
Closed
9
Calls
$29K
Puts
$4K
Net Calls
+$25K
Net Calls Change
+$1.33M
Top Buyers
Top Sellers
1 |
1
Goldman Sachs
New York
|
$0 |
2 |
2
Squarepoint
New York
|
$0 |
3 |
3
UBS Group
Zurich,
Switzerland
|
$64.4K |
4 |
![]()
4
Group One Trading
Chicago,
Illinois
|
$13.9K |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$4.9M |